Tag | Content |
---|
EnhancerAtlas ID | HS060-20859 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr2:225758990-225759920 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Rhox11 | MA0629.1 | chr2:225759026-225759043 | TTTCTTTACAGCATCAT | - | 6.08 | SPI1 | MA0080.4 | chr2:225759221-225759235 | AGAAAGAGGAAGTC | + | 6.21 | SPIC | MA0687.1 | chr2:225759221-225759235 | AGAAAGAGGAAGTC | + | 6.67 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_11129 | chr2:225757515-225763655 | CD20 | SE_18264 | chr2:225757474-225760548 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr2 | 225759181 | 225759393 | chr2 | 225759100 | 225759430 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I224893 | chr2 | 225758527 | 225760539 |
|
Enhancer Sequence | AGAATACTGT GAATGTGAAA TCTCTAATTT GCTTTCTTTC TTTACAGCAT CATGAATATA 60 AGGAAAGATG AACAGTGTTT GGGGATACAG CCACTGAAGA GTGTAATGGA CCTAAAGATG 120 GTGGGAACAC ATTTAGTTAA AAGGATGGCT AAATACGGCT GTCTCCATCC TCTCAACTTG 180 AGATGCAGTC TCCCAACTTC CGAGTTGTAA CCACTTCTCA GAACTATTTT CAGAAAGAGG 240 AAGTCCTGAT GTTAAAAGAT GCTTTGCTTT TCAGTTGTGC CTACAAAAAC TGTGTCATGA 300 ACACCCAGAC ATTCTGAATG TAACAATTAC TCATGAAAGC TTAGGGTGTG GTAAACCTTC 360 CCAACATGAA GTTGCAAGAG CTTGTCTATC AGCAGGGATT CAAGTCAAAA AGAATGCTCA 420 AAGATCTGGT AAACGTTACT GTTCAGTGTT TTGAAAAAAG ATTTGCAGTT TAGAAGGGAC 480 ATACTTTTTT TCTCTTCACG GTAATGAAAC CCCAAAATAA ATGGCCTCCT CCTGTCTTTT 540 TCTTCGATTG CCACCCCTGC AGTCCCATTC TCCATAGAGT AGCCCAAGAG TTCTTTCAAA 600 GAGGTAAACC AGATCATGCC ACACCCCTGG TTGAAATTTC CAAAGGCTTT TGTTGCAATG 660 AAAGTAAAAT CCAAGCTCCT TTCCAGGGCA CACAGGGTCC CTTGCCTAAG GTCCTTGGTT 720 TCATCTTATT ACGCCCCTTT CATCCTTAAG CTCTAGCCTT CCTGACTCAA GTGACCATAC 780 TGGTTCCCAC CACTTCAGGG TCTTTGCCTT GCTGCTTCTC CAGAATCCTT TCCCAAGATG 840 CCTGTGTTGG CAGCTACTGC CGATTCATAT CCAAGATCAA ATGTCACCTT CTTAAATCTA 900 GTTCATAATC CCTCTTTCAA ATTCCGCATT 930
|